Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis

by Yuchen Li, Qingkun Song, Bryan W. Day
Published 2019-07-01

Direct evidence for transport of RNA from the mouse brain to the germline and offspring

by Elizabeth A. O’Brien, Kathleen S. Ensbey, Bryan W. Day, Paul A. Baldock, Guy Barry
Published 2020-04-01

Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study

by Juliana Müller Bark, Juliana Müller Bark, Arutha Kulasinghe, Arutha Kulasinghe, Gunter Hartel, Paul Leo, Paul Leo, Majid Ebrahimi Warkiani, Rosalind L. Jeffree, Rosalind L. Jeffree, Rosalind L. Jeffree, Rosalind L. Jeffree, Benjamin Chua, Benjamin Chua, Bryan W. Day, Bryan W. Day, Bryan W. Day, Chamindie Punyadeera, Chamindie Punyadeera
Published 2021-06-01

Effectiveness of porous silicon nanoparticle treatment at inhibiting the migration of a heterogeneous glioma cell population

by Youssef Abdalla, Meihua Luo, Ermei Mäkilä, Bryan W. Day, Nicolas H. Voelcker, Wing Yin Tong
Published 2021-02-01

DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells

by Brianna Chen, Dylan McCuaig-Walton, Sean Tan, Andrew P. Montgomery, Bryan W. Day, Michael Kassiou, Lenka Munoz, Ariadna Recasens
Published 2021-04-01

EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study

by Simon Puttick, Brett W. Stringer, Bryan W. Day, Zara C. Bruce, Kathleen S. Ensbey, Karine Mardon, Gary J. Cowin, Kristofer J. Thurecht, Andrew K. Whittaker, Michael Fay, Andrew W. Boyd, Stephen Rose
Published 2015-07-01

Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma

by Seçkin Akgül, Ann-Marie Patch, Rochelle C.J. D’Souza, Pamela Mukhopadhyay, Katia Nones, Sarah Kempe, Stephen H. Kazakoff, Rosalind L. Jeffree, Brett W. Stringer, John V. Pearson, Nicola Waddell, Bryan W. Day
Published 2019-02-01

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S) in human breast cancers and matching brain metastases

by Priyakshi Kalita-de Croft, Malcolm Lim, Haarika Chittoory, Xavier M. de Luca, Jamie R. Kutasovic, Bryan W. Day, Fares Al-Ejeh, Peter T. Simpson, Amy E. McCart Reed, Sunil R. Lakhani, Jodi M. Saunus
Published 2020-07-01

Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells

by Ariadna Recasens, Sean J. Humphrey, Michael Ellis, Monira Hoque, Ramzi H. Abbassi, Brianna Chen, Mitchell Longworth, Elise J. Needham, David E. James, Terrance G. Johns, Bryan W. Day, Michael Kassiou, Pengyi Yang, Lenka Munoz
Published 2021-04-01

A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma

by Sakthi Lenin, Elise Ponthier, Kaitlin G. Scheer, Erica C. F. Yeo, Melinda N. Tea, Lisa M. Ebert, Mariana Oksdath Mansilla, Santosh Poonnoose, Ulrich Baumgartner, Bryan W. Day, Rebecca J. Ormsby, Stuart M. Pitson, Guillermo A. Gomez
Published 2021-04-01

Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States Are Maintained in 3D Culture

by Rochelle C. J. D’Souza, Carolin Offenhäuser, Jasmin Straube, Ulrich Baumgartner, Anja Kordowski, Yuchen Li, Brett W. Stringer, Hamish Alexander, Zarnie Lwin, Po-Ling Inglis, Rosalind L. Jeffree, Terrance G. Johns, Andrew W. Boyd, Bryan W. Day
Published 2020-01-01

MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells

by Athena F. Phoa, Ariadna Recasens, Fadi M. S. Gurgis, Tara A. Betts, Sharleen V. Menezes, Diep Chau, Kristiina Nordfors, Joonas Haapasalo, Hannu Haapasalo, Terrance G. Johns, Brett W. Stringer, Bryan W. Day, Michael E. Buckland, Najoua Lalaoui, Lenka Munoz
Published 2020-03-01

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma

by Carolin Offenhäuser, Fares Al-Ejeh, Simon Puttick, Kathleen S. Ensbey, Zara C. Bruce, Paul R. Jamieson, Fiona M. Smith, Brett W. Stringer, Benjamin Carrington, Adrian V. Fuchs, Craig A. Bell, Rosalind Jeffree, Stephen Rose, Kristofer J. Thurecht, Andrew W. Boyd, Bryan W. Day
Published 2018-12-01

Digenic inheritance of mutations in EPHA2 and SLC26A4 in Pendred syndrome

by Mengnan Li, Shin-ya Nishio, Chie Naruse, Meghan Riddell, Sabrina Sapski, Tatsuya Katsuno, Takao Hikita, Fatemeh Mizapourshafiyi, Fiona M. Smith, Leanne T. Cooper, Min Goo Lee, Masahide Asano, Thomas Boettger, Marcus Krueger, Astrid Wietelmann, Johannes Graumann, Bryan W. Day, Andrew W. Boyd, Stefan Offermanns, Shin-ichiro Kitajiri, Shin-ichi Usami, Masanori Nakayama
Published 2020-03-01

Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research

by Perry F. Bartlett, Terrance G. Johns, Thomas Robertson, David Johnson, David Kadrian, Wendy Findlay, Peter Lucas, Scott Campbell, Gert Tollesson, Craig Winter, Suzanne Allan, Po Inglis, Zara C. Bruce, Kathleen S. Ensbey, Paul R. Jamieson, Rosalind L. Jeffree, John Wilson, Brett W. Stringer, Bryan W. Day, Geoffrey W. Osborne, Andrew W. Boyd
Published 2013-04-01

Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy

by Lisa M Ebert, Wenbo Yu, Tessa Gargett, John Toubia, Paris M Kollis, Melinda N Tea, Brenton W Ebert, Cedric Bardy, Mark van den Hurk, Claudine S Bonder, Jim Manavis, Kathleen S Ensbey, Mariana Oksdath Mansilla, Kaitlin G Scheer, Sally L Perrin, Rebecca J Ormsby, Santosh Poonnoose, Barbara Koszyca, Stuart M Pitson, Bryan W Day, Guillermo A Gomez, Michael P Brown
Published 2020-01-01